Add Yahoo as a preferred source to see more of our stories on Google. Assemblyman Gregg Hart, D-Santa Barbara, the author of ABx2-1, watches the vote tally during a special session of the as his bill ...

Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, with the San Diego biotech now planning for a pivotal phase 3 trial later ...

Among patients with multiple myeloma (MM) undergoing autologous stem cell transplantation (ASCT), atrial fibrillation (AF) is a frequent and high-risk complication, according to a study published ...

WICHITA, Kan. (KWCH) - Kansas lawmakers advanced a bill that would ban the use of cell phones in schools, but now, the state board of education says the bill is unconstitutional. After hours of debate ...

Induction Nivolumab Before Chemoradiation in High-Risk Human Papillomavirus–Driven Oropharynx Cancers: IMMUNEBOOST-HPV, a Multicenter Randomized Phase II Trial TF was detectable in 75.4% of baseline ...

Rajesh started following the latest happenings in the world of Android around the release of the Nexus One and Samsung Galaxy S. After flashing custom ROMs and kernels on his beloved Galaxy S, he ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...

A new “non-kinetic effects cell” has helped push cyber operations to the forefront of specialized U.S. military missions such as the capture of Venezuela's leader in the capital of Caracas, a top ...

Q. Dan, I came across one of your articles in which one of the questioners stated, “I have three IRAs.” Is that normal? Why would anyone need more than one? — Ben in Cocoa Beach A: Ben, most people ...

The peritoneal immune landscape in gastrointestinal peritoneal metastasis patients and the impact of intraperitoneal paclitaxel. HLA-I LoH (%) 21.2 28.8 24.9 HLA-I Hom (&) 22.3 25.3 25.5 HLA-A,B,C LoH ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with longer PFS, suggesting T-cell composition may serve as a biomarker to ...